StockSelector.com
  Research, Select, & Monitor Saturday, November 18, 2017 8:19:13 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
United Therapeutics Corp.$123.02$1.401.15%

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

United Therapeutics Corp. has an overall rank of 268 out of 7150 stocks based on 14 positive rankings and 6 negative rankings.

Positive Rankings
Highest ROA
United Therapeutics rank is 71
Highest Cash Growth
United Therapeutics rank is 127
Up Estimate Revision
During the past month, the consensus earnings estimate for the current year and next year have increased by a combined 8.17%. Among companies that have had their estimates raised within the past month, United Therapeutics is ranked 207.
Highest ROE
United Therapeutics rank is 212
Historic EPS Growth
United Therapeutics rank is 232
Top Industry Values
United Therapeutics rank is 293
Highest Net Margin
United Therapeutics rank is 308
Up EPS Surprise
United Therapeutics beat the consensus earnings estimate when it last reported quarterly earnings.
Debt-to-Equity
United Therapeutics rank is 574
Historic Revenue Growth
United Therapeutics rank is 774
Low Put/Call
United Therapeutics has a low Put/Call ratio of 0.34 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, United Therapeutics is ranked 830.
Low vPut/Call
United Therapeutics has a low Put/Call ratio of 0.42 on active options expiring within the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, United Therapeutics is ranked 927.
Low/Rising MACD
The MACD remains negative, but is rising... suggesting a possible near-term correction. Of companies with a negative, but rising MACD, United Therapeutics is ranked 1108.
10 Day Gain
United Therapeutics rank is 1431
Negative Rankings
Negative EPS Growth
United Therapeutics rank is 103
Negative Revenue Estimate
United Therapeutics rank is 104
Overbought Stochastics
United Therapeutics rank is 587
90 Day Loss
United Therapeutics rank is 1348
Price-to-Book
United Therapeutics rank is 1800
Price-to-Sales
United Therapeutics rank is 1803







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2017 StockSelector.com. All rights reserved.